Ongoing research into this medication are showcasing significant outcomes regarding body composition . Initially intended for addressing type 2 diabetes , this GLP-1 receptor agonist has shown https://techonpage.com/story6954872/semaglutide-research-unlocking-potential-body-shaping-possibilities